Anti-DAAM1 monoclonal antibody

Anti-DAAM1 antibody for FACS & in-vivo assay

Target products collectionGo to DAAM1/DAAM1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP2074-Ab-1/ GM-Tg-hg-MP2074-Ab-2Anti-Human DAAM1 monoclonal antibodyHuman
GM-Tg-rg-MP2074-Ab-1/ GM-Tg-rg-MP2074-Ab-2Anti-Rat DAAM1 monoclonal antibodyRat
GM-Tg-mg-MP2074-Ab-1/ GM-Tg-mg-MP2074-Ab-2Anti-Mouse DAAM1 monoclonal antibodyMouse
GM-Tg-cynog-MP2074-Ab-1/ GM-Tg-cynog-MP2074-Ab-2Anti-Cynomolgus/ Rhesus macaque DAAM1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP2074-Ab-1/ GM-Tg-felg-MP2074-Ab-2Anti-Feline DAAM1 monoclonal antibodyFeline
GM-Tg-cang-MP2074-Ab-1/ GM-Tg-cang-MP2074-Ab-2Anti-Canine DAAM1 monoclonal antibodyCanine
GM-Tg-bovg-MP2074-Ab-1/ GM-Tg-bovg-MP2074-Ab-2Anti-Bovine DAAM1 monoclonal antibodyBovine
GM-Tg-equg-MP2074-Ab-1/ GM-Tg-equg-MP2074-Ab-2Anti-Equine DAAM1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP2074-Ab-1/ GM-Tg-hg-MP2074-Ab-2; GM-Tg-rg-MP2074-Ab-1/ GM-Tg-rg-MP2074-Ab-2;
GM-Tg-mg-MP2074-Ab-1/ GM-Tg-mg-MP2074-Ab-2; GM-Tg-cynog-MP2074-Ab-1/ GM-Tg-cynog-MP2074-Ab-2;
GM-Tg-felg-MP2074-Ab-1/ GM-Tg-felg-MP2074-Ab-2; GM-Tg-cang-MP2074-Ab-1/ GM-Tg-cang-MP2074-Ab-2;
GM-Tg-bovg-MP2074-Ab-1/ GM-Tg-bovg-MP2074-Ab-2; GM-Tg-equg-MP2074-Ab-1/ GM-Tg-equg-MP2074-Ab-2
Products NameAnti-DAAM1 monoclonal antibody
Formatmab
Target NameDAAM1
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-DAAM1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species DAAM1 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP2074
    Target NameDAAM1
    Gene ID23002,208846,314212,701706,490714,101098546,513742,100051203
    Gene Symbol and SynonymsDAAM1
    Uniprot AccessionQ9Y4D1
    Uniprot Entry NameDAAM1_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000100592
    Target ClassificationN/A

    The target: DAAM1, gene name: DAAM1, also named as . Cell motility, adhesion, cytokinesis, and other functions of the cell cortex are mediated by reorganization of the actin cytoskeleton and several formin homology (FH) proteins have been associated with these processes. The protein encoded by this gene contains two FH domains and belongs to a novel FH protein subfamily implicated in cell polarity. A key regulator of cytoskeletal architecture, the small GTPase Rho, is activated during development by Wnt/Fz signaling to control cell polarity and movement. The protein encoded by this gene is thought to function as a scaffolding protein for the Wnt-induced assembly of a disheveled (Dvl)-Rho complex. This protein also promotes the nucleation and elongation of new actin filaments and regulates cell growth through the stabilization of microtubules. Alternative splicing results in multiple transcript variants encoding distinct proteins. [provided by RefSeq, Jul 2012].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.